Search clinical trials for: prognostic factor

Total 37553 results

Sanofi

Completed

Study of the Effect of SR57667B in Patients With Alzheimer's Disease

Alzheimer Disease
Hamilton Health Sciences Corporation
St. Joseph's Healthcare Hamilton

Unknown

Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population

Bleeding | End Stage Renal Disease

Canada
University of Aarhus

Completed

Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?

Vitamin B12 Deficiency

Denmark
National Taiwan University Hospital
Schering-Plough

Completed

Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B

Chronic Hepatitis B
National Cancer Institute, Milan
Associazione Italiana per la Ricerca sul Cancro

Completed

Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis

Liver Cirrhosis | Hepatocellular Carcinoma | Hepatitis C Virus Infection | Hepatic Resection | Interferon Treatment

Italy
West Japan Thoracic Oncology Group

Unknown

Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer

Lung Cancer

Japan
University of Saskatchewan
Saskatchewan Health Research Foundation

Completed

Aquatic Verses Land Exercise to Decrease Fall Risk

Osteoporosis

Canada
Peking University

Completed

Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone

Nephritis, Lupus

China
Inje University

Unknown

Random Trial for Elderly Patients With NSCLC

Non-Small Cell Lung Cancer

Korea, Republic of
Children´s Clinic, Randers

Completed

Short Term Growth in Children With Atopic Dermatitis

Atopic Dermatitis
Charite University, Berlin, Germany

Unknown

Methotrexate in Ankylosing Spondylitis (MTX in AS)

Ankylosing Spondylitis

Germany
Chiron Corporation

Unknown

Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine

Meningococcal Disease; Meningococcal Meningitis

United Kingdom
National Health Research Institutes, Taiwan

Completed

A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers

Non-Hodgkin's Lymphoma

Taiwan
University of Oslo School of Pharmacy

Completed

Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk

Renal Transplant Recipients
University Hospital Muenster
KKS Netzwerk; Proverum GmbH; Fujisawa GmbH

Unknown

Efficacy and Safety of Sirolimus in Combination With Tacrolimus

Kidney Transplantation

Germany
The University of Hong Kong

Completed

Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC

Hepatocellular Carcinoma
University College London Hospitals

Completed

Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 Eradication

Chronic Hepatitis C, HCV Genotype 1

United Kingdom
St. John Providence Health System
Eli Lilly and Company; Genentech, Inc.

Unknown

Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

Non-Small Cell Lung Cancer

United States
National Taiwan University Hospital

Terminated

A Study on Etiological Factors of Schizophrenia

Schizophrenia
National Taiwan University Hospital

Unknown

Immunologic Factors in Reflux Esophagitis and Barrett's Esophagus

Hiatal Hernia | Reflux Esophagitis

Taiwan
Poitiers University Hospital
Novartis; Ministry of Health, France

Terminated

Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients

Chronic Myeloid Leukemia

France
National Taiwan University Hospital

Unknown

Risk Factors of Radiation Pneumonitis

Radiation Pneumonitis

Taiwan
Celgene Corporation
Prologue Research International

Terminated

A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer.

Prostate Cancer

United States
Hannover Medical School
University Hospital, Ghent; Johann Wolfgang Goethe University Hospital; University... and other collaborators

Unknown

Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T

De Novo Akute Myeloid Leukemia (AML) | Secondary Acute Myeloid Leukemia (AML) | Refractory Anemia With Excess of Blasts in Transformation

Germany
Children's Memorial Health Institute, Poland

Completed

Comparison of Immunosuppression Protocols After LTx in Children

Liver Transplantation

Poland
NS Pharma, Inc.

Completed

Study of NS-9 in Patients With Liver Metastases

Neoplasm Metastasis | Liver Neoplasms | Local Neoplasm Recurrences

United States
Corixa Corporation

Unknown

A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United States
Celgene Corporation
Prologue Research International

Terminated

Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Celgene Corporation
Prologue Research International

Terminated

A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas

Pancreatic Cancer

United States
Zeneus Pharma

Unknown

Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.

Aggressive Non-Hodgkin's Lymphoma in the Elderly.

France, Germany, Spain, United Kingdom, Italy
University Hospital, Angers
French Innovative Leukemia Organisation

Unknown

Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia

Adult Acute Lymphoblastic Leukemia

France
University Hospital Schleswig-Holstein

Completed

Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation

Renal Transplantation
Assistance Publique - Hôpitaux de Paris
Etablissement Français du Sang

Terminated

Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy

Autoimmune Thrombocytopenic Purpura

France
National Taiwan University Hospital

Completed

Indications and Related Factors for Caesarean Delivery, 1996 to 2002.

Labor

Taiwan
Johann Wolfgang Goethe University Hospital

Unknown

Efficacy of G-CSF-Priming in Elderly AML Patients

Acute Myeloid Leukemia

Germany
Chang Gung Memorial Hospital

Unknown

Pituitary Derived-Intermedin is an Estrogen-Modulated Factor for Reducing Blood Pressure

Hypertension | Menopause

Taiwan
University Hospital Schleswig-Holstein

Completed

Investigation of the Steady State Pharmacokinetics of Tacrolimus, Mycophenolate Mofetil and Fluvastatin After Renal Transplantation

Renal Transplantation
Edward Hines Jr. VA Hospital

Unknown

PST/Laser v. Laser Alone for CSME

Diabetic Retinopathy

United States
Kyoto University, Graduate School of Medicine

Unknown

Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure

Liver Failure, Acute

Japan
Risk Factor Modification Centre
Ontario Ginseng Growers Association; Ontario Ministry of Agriculture, Food...

Completed

The Effect of North American Ginseng on Blood Pressure in Individuals With Hypertension

Hypertension

Canada
Austin Health

Unknown

"Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery

Myocardial Ischemia | Coronary Artery Disease | Blood Coagulation Disorders | Heart Valve Diseases

Australia
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR); Population Health Research Institute

Unknown

Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)

Cardiovascular Disease | Atherosclerosis

Canada
Hvidovre University Hospital

Completed

Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis

Rheumatoid Arthritis

Denmark
Hokkaido Gastrointestinal Cancer Study Group

Completed

Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer

Colorectal Cancer

Japan
Odense University Hospital

Completed

Patients Preference for Oral or i.v. Therapy

Colorectal Cancer

Denmark
University Hospital, Strasbourg, France

Completed

Risk Factors of Porphyria Cutanea Tarda (PCT)

Porphyria Cutanea Tarda
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; Taipei Veterans... and other collaborators

Completed

A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen

Non-Hodgkin's Lymphoma

Taiwan
Association Européenne de Recherche en Oncologie
Pfizer; Aventis Pharmaceuticals

Unknown

5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer

Cancer of the Rectum

France
Association Européenne de Recherche en Oncologie
Bristol-Myers Squibb

Unknown

6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast Cancer

Breast Cancer
University Health Network, Toronto
Stanley Medical Research Institute

Unknown

Psychoeducation Versus Cognitive-Behavioral Therapy in Bipolar Disorder

Bipolar Disorder

Canada

Search clinical trials for: prognostic factor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations